EPIUnit, Institute of Public Health of the University of Porto, Porto, Portugal; Department of Internal Medicine, Centro Hospitalar Vila Nova de Gaia Espinho, Vila Nova de Gaia, Portugal.
EPIUnit, Institute of Public Health of the University of Porto, Porto, Portugal.
Can J Cardiol. 2018 Oct;34(10):1325-1332. doi: 10.1016/j.cjca.2018.06.006. Epub 2018 Jun 15.
Chronic kidney disease is a frequent comorbidity in heart failure (HF), associated with increased mortality. The impact of temporal evolution of kidney function in HF prognosis is largely unknown. We evaluated the effect of renal function over time in all-cause mortality among ambulatory patients with HF.
We retrospectively analyzed data from 560 patients with HF with left ventricular systolic dysfunction followed for a median of 25.1 months at an outpatient clinic. Demographics and comorbidities were collected at baseline. Creatinine values were abstracted from records at each clinical visit. Kidney function was assessed by estimated glomerular filtration rate (eGFR) and was categorized into 3 classes. Extended Cox models were performed to study the association between time-varying eGFR and death.
Patients' mean age was 67.5 ± 13.9 years, 67.0% were men, 46.1% had ischemic etiology, the majority had moderate-to-severe left ventricular systolic dysfunction, and 45.9% had chronic kidney disease at baseline. The eGFR declined approximately 9.0 mL/min/1.73 m over 5 years. In crude analysis, time-varying eGFR had a significant dose-dependent association with death (hazard ratio [HR] = 1.34, 95% confidence interval [CI]: 1.03-1.75 for eGFR between 30 and 60 mL/min/1.73 m; HR = 1.55, 95% CI: 1.11-2.17 for <30 mL/min/1.73 m). The prognostic value of time-varying eGFR was totally explained by baseline comorbidities, indicators of HF severity and drugs (adjusted HR = 1.11, 95% CI: 0.83-1.48; HR = 1.19, 95% CI: 0.79-1.80, for eGFR 30-60 and <30 mL/min/m, respectively).
Time-varying kidney function is not independently related to poor prognosis in HF. Rather than directly affecting survival, renal impairment is probably a surrogate marker of HF severity.
慢性肾脏病是心力衰竭(HF)的常见合并症,与死亡率增加有关。肾功能随时间的变化对 HF 预后的影响在很大程度上尚不清楚。我们评估了 HF 门诊患者肾功能随时间变化对全因死亡率的影响。
我们回顾性分析了 560 例左心室收缩功能障碍的 HF 患者的数据,这些患者在门诊接受了中位数为 25.1 个月的随访。基线时收集了人口统计学和合并症数据。每次就诊时从记录中提取肌酐值。通过估算肾小球滤过率(eGFR)评估肾功能,并分为 3 类。进行扩展 Cox 模型研究时间变化的 eGFR 与死亡之间的关系。
患者的平均年龄为 67.5±13.9 岁,67.0%为男性,46.1%有缺血性病因,大多数有中重度左心室收缩功能障碍,基线时有 45.9%患有慢性肾脏病。5 年内 eGFR 下降约 9.0 mL/min/1.73 m。在粗分析中,时间变化的 eGFR 与死亡呈显著剂量依赖性相关(危险比 [HR] 为 1.34,95%置信区间 [CI]:30-60 mL/min/1.73 m 之间为 1.03-1.75;<30 mL/min/1.73 m 之间为 1.55,95%CI:1.11-2.17)。时间变化的 eGFR 的预后价值完全由基线合并症、HF 严重程度和药物的指标解释(调整后的 HR 为 1.11,95%CI:0.83-1.48;HR 为 1.19,95%CI:0.79-1.80,分别为 eGFR 为 30-60 和<30 mL/min/m)。
时间变化的肾功能与 HF 不良预后无独立关系。肾功能损害可能不是直接影响生存的因素,而是 HF 严重程度的替代标志物。